Inhaled Beta-2 Agonist Versus Epinephrine For Treatment of Transient Tachypnea of Newborn (TTN)

PHASE1CompletedINTERVENTIONAL

Enrollment

135

Participants

Timeline

Start Date

February 1, 2014

Primary Completion Date

December 31, 2015

Study Completion Date

December 31, 2015

Conditions

Transient Tachypnea of the Newborn

Interventions

DRUG

Epinephrine Inhalation Solution

DRUG

Salbutamol

DRUG

Saline Inhalants

All Listed Sponsors

lead

Ahmed Noaman

OTHER

NCT05006235 - Inhaled Beta-2 Agonist Versus Epinephrine For Treatment of Transient Tachypnea of Newborn (TTN) | Biotech Hunter | Biotech Hunter